Creagen
UEI: TR7EMJYU1KL9
• CAGE: 4TEG8
• SBA Certs:
8(a)
Overview
Awardee Type
Parent
Federal Capability Statement
CreaGen Inc. provides contract research services in organic synthesis, medicinal chemistry, lead optimization, small molecules, chemical library synthesis, conjugation chemistry, and antibody drug conjugation chemistry, analytical and bio-analytical chemistry.
We have more than 100 years of combined experience in working with over 48 biotech and pharmaceutical companies and federal institutes.
Our 22,000 sq ft facility has a full suite of infrastructure for synthesis, purification and characterization combined with a highly qualified team of chemists putting us in a strong position to deliver unparalleled drug discovery services to biotech, pharmaceutical companies and Federal research laboratories.
Keywords
Contract Research, synthetic organic chemistry, medicinal chemistry, Anti-viral research, Anti infective research. Corona virus, COVID-19 research, Oncology, Lead Optimization, Organic Chemistry, Parallel synthesis, Building Blocks synthesis, SAR Optimization, Active Pharmaceutical Intermediates, Drug-Protein, Drug Conjugation, Small Molecule, Antibody Drug Conjugates, Pharmaceuticals, peptides, nucleosides, PNA, DNA, RNA.
SBA Special Equipment
Specialized instruments at CreaGen: 300 MHz Varian multi nuclear NMR; , Waters Micromass Quatro Ultima LCMS (triple-quad MS), Waters Autopurification System with SQ3100 Mass Detector, HP 1200 analytical HPLC; HP-1100 preparative HPLC, Waters chiral SFC and UPLC systems, Sedex 55 ELSD system Teledyne-Isco Combiflash-RF purification system, Waters Alliance HT 2790 Separations Module, Automated parallel synthesis instruments, Parr hydrogenation apparatus; Microwave reactor, Semi-automated parallel synthesizers (TCAMS). Automated liquid handlers and high speed evaporators.
Website
Headquarters
Woburn, MA
United States
United States
Most Recent Award
Aug. 12, 2024
Calculating
Federal contract recipient
CREAGEN INC
(UEI TR7EMJYU1KL9, CAGE 4TEG8)
is headquartered in Woburn MA.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in April 2003 and
federally registered in
July 2007.
Federal Award Analysis
Creagen federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CREAGEN INC
UEI
TR7EMJYU1KL9
CAGE Code
4TEG8
Primary NAICS
SBA 8(a) Certification
Yes (Aug. 26, 2017 - Aug. 26, 2027)
Other SBA Certifications
None
Self Certifications
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 14, 2003
Initial Registration
July 12, 2007
Last Registration
Nov. 26, 2024
Registration Activation
Nov. 26, 2024
Registration Expiration
Nov. 22, 2025
Fiscal Year End
December 31
Reported Entity Types
8(a) Active
For Profit Organization
For Profit Organization
State of Incorporation
MA
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes